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Purpose: Single dose gadolinium (Gd) enhanced fluid-attenuated inversion recov-
ery (FLAIR) is helpful for visualizing superficial parenchymal metastases. Howev-
er, the usefulness of FLAIR with a higher dose of Gd is uncertain. The aim of our 
study was two-folds: first, to prove that the signal to noise ratio (SNR) of small 
brain metastases is higher than large brain metastases on double-dose (DD) en-
hanced FLAIR and, second, to explore the added value of DD Gd enhanced FLAIR 
in relation to T1 GRE for evaluating small brain metastases. Materials and Meth-
ods: For the first purpose, 50 pairs of small (2 mm<diameter≤5 mm) and large 
brain metastases (diameter >5 mm) were included. The difference in the SNR and 
contrast ratio (CR) between small and large metastases on DD Gd-enhanced 3D T2 
FLAIR was compared by Wilcoxon signed-rank tests. For the second purpose, a to-
tal of 404 small metastases were included. The diagnostic sensitivities between 3D 
T1 gradient echo (GRE) alone and combined results of 3D T1 GRE and 3D T2 
FLAIR were compared with McNemar test. Results: The SNR and CR of small 
brain metastases were significantly higher than those of large brain metastases 
(p<0.001). In qualitative analysis, the diagnostic sensitivities for small brain metas-
tases were significantly higher for 3D T1 GRE plus 3D T2 FLAIR than 3D T1 
GRE alone regardless of scan time (p<0.001). Conclusion: Small brain metastases 
showed higher signal intensity than large brain metastases on the DD Gd enhanced 
3D T2 FLAIR images. DD Gd enhanced 3D T2 FLAIR imaging may have a com-
plementary role to 3D T1 GRE for evaluating small brain metastases.
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INTRODUCTION
Accurate assessment of the number, location, and volume of metastases is impor-
tant for establishing a diagnosis and planning treatment strategies.1-3 Contrast-en-
hanced MR is the modality of choice for evaluating brain metastases. A higher 
dose of gadolinium (Gd) contrast material could provide higher diagnostic yield in 
the detection of brain metastases if contrast-related complications, such as nephro-
genic systemic fibrosis, are minimized.4-7 Yuh, et al.6 reported double dose (DD) 
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found to have brain metastases and were excluded from the 
study. Diagnosis of brain metastasis was established by inter-
preting the initial and follow up DD Gd-enhanced 3D T1 
GRE images. After examining the follow-up MRI scans, 
patients were confirmed as having metastatic brain tumors 
if their lesions increased in size with time or decreased in 
size following radiation therapy with or without chemother-
apy. Lesions showing equivocal change in size on a follow-
up MRI scan were regarded as probable metastases. Twen-
ty-one cases that showed severe MRI artifacts were also 
excluded. A total of 128 cases were selected for quantitative 
and qualitative analysis in this study. 
Subpopulation for quantitative analysis
Out 128 cases total, patients who had both small brain me-
tastases (≤5 mm diameter) and larger metastases (>5 mm di-
ameter) were included. Patients who had only one of small 
or larger metastases were excluded. Patients with tumors 
that were too small (less than 2 mm) to accurately measure 
were also excluded from the study. These criteria were satis-
fied by 25 patients (12 males, 13 females; age range: 41--78 
years; mean: 58.4 years). The primary sites of metastasis 
were the lungs (n=12), breasts (n=7), kidneys (n=3), esopha-
gus (n=1), colon (n=1), and gallbladder (n=1). 
Subpopulation for qualitative analysis
Out of a total of 128 cases, patients who had small metasta-
ses were included regardless of the presence of large tu-
mors; 72 (37 males, 35 females; age range: 37--79 years; 
mean: 58.6 years) were confirmed as having small brain 
metastases. Their primary tumor sites were the lung (n=51), 
breast (n=11), kidney (n=4), melanoma (n=2), esophagus 
(n=1), colon (n=1), gallbladder (n=1), and peripheral nerve 
(n=1). According to retrospective review of our protocol, 
MRI was scanned in the order of 3D T1 GRE and 3D T2 
FLAIR (defined as delayed phase 3D T2 FLAIR) after Gd 
injection for 40 of the 72 patients and in the reverse order 
(defined as early phase 3D T2 FLAIR) for 32 of the 72. 
MR imaging and contrast agent administration
All MR images were acquired using a 3T scanner (Achieva 
or Intera; Philips Medical Systems, Best, the Netherlands). 
An institutional MR imaging protocol for brain metastases 
(routine anatomic T1/T2 weighted images) was established. 
After administration of DD gadoteric acid (0.2 mmol/kg), 
3D T1 GRE and 3D T2 FLAIR images were obtained. The 
parameters of 3D T1 3D GRE imaging were as follows: 
Gd-enhanced T1 weighted image (T1WI) has advantages 
over single dose Gd in detecting early and small brain me-
tastases. They also reported triple dose Gd enhanced T1WI 
appeared to be more effective than delayed imaging with 
standard dose.4 Therefore, DD Gd enhanced T1WI is pre-
sumed to have at least a similar or higher level of diagnos-
tic yield of detecting brain metastases over SD Gd. 
Several previous studies proved that SD Gd-enhanced 
fluid-attenuated inversion recovery (FLAIR) is useful in the 
evaluation of superficial metastases and leptomeningeal 
metastases, because this sequence does not lead to contrast 
enhancement of vessels.8-11 However, the optimal dose of Gd 
to maximize the detection of metastases on Gd-enhanced 
FLAIR is undetermined, and unlike T1 weighted images, 
FLAIR with higher dose of Gd might not provide high di-
agnostic yield in the detection of brain metastases, because 
an increase in the T2 effect obscures the enhancing T1 ef-
fect.8,12 Several institutions use enhanced T1WI with DD 
Gd to evaluate brain metastasis. Therefore, the issue of 
whether enhanced FLAIR in the setting of DD Gd has a 
complementary role to T1WI is critical.
We hypothesize that small brain metastases might have 
higher signal intensities than large metastases in the setting of 
double dose of Gd injection, because small brain metastases 
might have less Gd contrast medium than large brain metas-
tases. DD Gd-enhanced 3D FLAIR might be still effective 
for detecting small brain metastasis. Therefore, the purpose 
of our study was two-fold: first, we aimed to prove that the 
signal-to-noise ratio (SNR) of small brain metastases is high-
er than the SNR of large brain metastases on DD dose Gd 
enhanced 3D T2 FLAIR. Secondly, we aimed to explore the 
added value of DD Gd enhanced 3D T2 FLAIR in relation to 
3D T1 GRE for detection of small brain metastases.
MATERIALS AND METHODS
　　　
Patient population
Approval by the Institutional Review Board was obtained 
and informed consent was waived for this retrospective 
study. Patients who had neurologic symptoms routinely un-
derwent DD contrast-enhanced MR imaging at the outpatient 
oncology clinic of our institution to screen for cancer metas-
tases in the brain; gadoterate meglumine was used as the 
contrast material. Between June 2012 and August 2012, 216 
consecutive patients were imaged with MRI using the metas-
tasis protocol of our institution. Of these, 67 patients were not 
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brain metastases using only DD Gd enhanced 3D T1 GRE. 
Intraclass correlation coefficient was measured between the 
two reviewers. Numbers of metastases for further analysis 
were determined by consensus between the two readers. At 
the second session after 2 weeks, they reviewed 3D FLAIR 
and 3D T1 GRE simultaneously and recorded the existence 
or non existence of small brain metastases. Intraobserver 
variability was analyzed. Numbers of metastases for further 
analysis were also determined by consensus between the 
two reviewers. Lesions detected only on 3D T2 FLAIR but 
not on 3D T1 GRE were counted as metastasis based on the 
following criteria: first, the location of lesions had to be su-
perficial. Secondly, the morphology of lesions was nodular. 
Thirdly, signal intensity of the lesions was similar to that 
for the choroid plexus. Lesions that were located in the 
deep white matter or showed a signal intensity that was not 
as high as the choroid plexus of the lateral ventricle were 
regarded as a white matter lesion, such as leukoaraiosis. 
The standard reference was initial and follow-up 3D T1 
GRE. Diagnostic sensitivities of DD post 3D T1 GRE and 
combination of DD post 3D T1 GRE and 3D T2 FLAIR 
were compared using the McNemar test. Comparison of the 
number of metastases was analyzed using the Wilcoxon 
singed rank test. p-values <0.05 were considered statistical-
ly significant.
 
RESULTS
 
Quantitative image analysis
The SNRs and CRs of small brain metastases were signifi-
cantly higher than those of large metastases (Fig. 1). The 
mean SNR±SD of small and large brain metastases were 
32.82±13.03 and 19.38±11.73 for post contrast 3D T2 FLAIR 
(p<0.001) (Fig. 2). The mean CR±SD of small and large brain 
metastases were 2.14±0.57 and 1.29±0.63 (p<0.001).
 
Qualitative image analysis
Four hundred and four small brain metastases were record-
ed after reviewing both initial and follow up 3D T1 GRE 
(242 for 3D T1 GRE taken in the early phase, 162 for 3D 
T1 GRE taken in the late phase). Out of the 242 metastases, 
185 metastases (76.45%) were detected on the early phase 
3D T1 GRE alone. Meanwhile, 242 metastases (100%) were 
detected on early phase 3D T1 GRE plus 3D T2 FLAIR, 
which was significantly more than those on early phase 3D 
T1 alone (p<0.001, Wilcoxon signed-rank test). The diag-
TR/TE, 9.8/4.5 ms; flip angle, 8°; bandwidth, 190.8 Hz/pix-
el; 224×224 matrix with 224 phase-encoding steps; 1 mm 
section thickness; and a 22-cm FOV. The parameters for 
3D T2 FLAIR imaging were as follows: TR/TE, 8000/342 
ms; TI 2400 ms using the same matrix size, phase encoding 
steps, section thickness and the same FOV as the 3D T1 
GRE. Post-Gd 3D T1 GRE images were acquired 3 min af-
ter the Gd injection. Scanning time for 3D T1 GRE was 5 
min 30 s. Right after 3D T1 GRE, the 3D T2 FLAIR image 
was acquired; its scanning time was 8 min 40 s. When MRI 
was scanned in the reverse order, the 3D T2 FLAIR image 
and 3D T1 GRE were acquired without pause after Gd in-
jection. 
Imaging analysis
Quantitative analysis
Quantitative analysis was performed by a board-certified 
neuroradiologist (A.S.J). Two pairs of metastases per pa-
tient (two small metastasis and two large metastasis) were 
selected in the quantitative analysis. We regarded the two 
largest metastases as representative lesions for large brain 
metastasis and regarded the two smallest metastases as rep-
resentative lesions for small brain metastases to maximize 
the size difference. A total of 50 pairs of small brain and 
large brain metastases were analyzed. The representative le-
sions were to have shown homogeneous enhancement with-
out hemorrhage, necrosis, and fibrosis. The largest possible 
circular region of interest was drawn in the enhancing por-
tion of each brain lesion and frontal white matter on the 
post contrast 3D T2 FLAIR image. 
SNR was measured for these lesions. The standard devia-
tion (SD) of the signal intensity (SI) of the background 
could not be used as a measure of noise in the parallel imag-
ing.13 Instead, we used homogenous tissue, such as frontal 
white matter close to the target lesion, to measure noise.14 
We estimated the SNR as follows: SImetastasis/SDfrontalWM. We 
also defined contrast ratio (CR) of metastasis to normal pa-
renchyma as the signal intensity of metastasis over that of 
frontal white matter. Wilcoxon signed rank tests were per-
formed to evaluate the statistical significance of differences 
in SNR and CR between small and large metastases on post 
contrast 3D T2 FLAIR images.
Qualitative analysis
Two experienced neuroradiologists independently reviewed 
all the brain images. At the first session, they recorded small 
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Of the 404 metastases, 162 metastases were discovered 
when 3D T1 GRE was taken in the delayed phase. One 
hundred and forty six out of 162 metastases (90.57%) were 
detected on delayed 3D T1 GRE alone. Meanwhile, 162 
metastases (100%) were detected on delayed 3D T1 GRE 
plus early 3D T2 FLAIR, which was significantly more 
than those on delayed 3D T1 GRE alone (p=0.003, Wilcox-
on signed-rank test). The diagnostic sensitivities for small 
brain metastases were significantly higher for delayed 3D 
T1 GRE plus early 3D T2 FLAIR than delayed 3D T1 
nostic sensitivities for small brain metastases were signifi-
cantly higher for early 3D T1 GRE plus delayed 3D T2 
FLAIR than early 3D T1 GRE alone (p<0.001, McNemar 
test) (Table 1). DD enhanced early phase 3D T1 GRE missed 
57 metastases that were detected with early 3D T1 GRE and 
delayed 3D T2 FLAIR. Out of the 57 missed metastases, 52 
metastases (92%) showed enhancement on early 3D T1 
GRE, but were not detected by both reviewers (Fig. 3). Five 
metastases (8%) showed no enhancement on early 3D T1 
GRE (Fig. 4).
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Fig. 1. Comparison of SNR and CR between small metastasis (2 mm<diameter≤5 mm) and large metastasis (diameter >5 mm) on DD Gd enhanced 3D T2 
FLAIR. (A) SNRs of small and large brain metastases (32.82±13.03 vs. 19.38±11.73). (B) CRs of small and large brain metastases (2.14±0.57 vs. 1.29±0.63). SNR, 
signal-to-noise ratio; DD, double dose; Gd, gadolinium; FLAIR, fluid-attenuated inversion recovery; CR, contrast ratio.
Fig. 2. A 45-year-old patient with renal cell cancer. (A) A larger brain metastasis (8 mm) with dark signal intensity and peri-lesional edema in the left frontal 
lobe on DD Gd-enhanced 3D T2 FLAIR (SNR: 9.61). (B) The same lesion with strong enhancement on post DD gadolinium enhanced 3D T1 GRE. (C) Another 
small brain metastasis (4.2 mm) in the left frontal lobe with high signal intensity on DD Gd-enhanced 3D T2 FLAIR (SNR: 21.63). (D) The same lesion with en-
hancement on DD Gd-enhanced 3D T1 GRE. SNR, signal-to-noise ratio; DD, double dose; Gd, gadolinium; FLAIR, fluid-attenuated inversion recovery; GRE, 
gradient echo.
Table 1. Comparison of Metastasis Detection between 3D T1 GRE Alone and 3D T1 GRE Plus 3D T2 FLAIR When 3D T2 FLAIR 
Was Taken in the Delayed Phase after DD Gd Injection 
Early phase 3D T1 GRE
Early phase 3D T1 GRE+delayed 
phase 3D T2 FLAIR 
p value 
Parenchymal metastases 242
Number of metastasis 185 242 <0.001
Sensitivity (%) 76.45 100 <0.001
ICC     0.981 0.873
FLAIR, fluid-attenuated inversion recovery; DD, double dose; Gd, gadolinium; GRE, gradient echo; ICC, intraclass correlation coefficient.
Data are means±SD.
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DD Gd-enhanced 3D T2 FLAIR might be explained by the 
increased concentration of Gd from altered tumor environ-
ments, such as progression of angiogenesis and increase in 
the amount of paramagnetic materials, such as microhem-
orrhage or extracranial primary tissue, suppressing the T1 
shortening effect.16-19 Based on our quantitative results, we 
focused the qualitative analysis on small brain parenchymal 
metastasis (less than 5 mm in diameter). In addition, accu-
GRE alone (p<0.001, McNemar test) (Table 2). DD en-
hanced delayed 3D T1 GRE missed 16 metastases that 
were detected with delayed 3D T1 GRE and early 3D T2 
FLAIR. Sixteen missed metastases showed enhancement 
on delayed phase 3D T1 GRE, but were not detected by 
both reviewers. 
Intraclass correlation coefficients between both reviewers 
were excellent regardless of scan timing (0.873 for delayed 
T2 FLAIR, 0.941 for early T2 FLAIR).
DISCUSSION
Gd enhanced FLAIR imaging is a useful tool for detecting 
superficial parenchymal and meningeal lesions.8,9,15 Howev-
er, unlike in T1WI scans, signal intensity on FLAIR images 
decreases as Gd concentration increases because of an in-
crease in the T2 shortening effect. We set out to explore 
whether contrast enhanced FLAIR imaging has diagnostic 
value for brain metastases when a double dose of Gd con-
trast material is used.
According to our results, small brain metastatic lesions 
have a higher SNR than large brain metastases. The rela-
tively lower signal intensity of large brain metastases on 
Table 2. Comparison of Metastasis Detection between 3D T1 GRE Alone and 3D T1 GRE Plus 3D T2 FLAIR When 3D T2 FLAIR 
Was Taken in the Early Phase after DD Gd Injection
Delayed phase 3D T1 GRE
Early phase 3D T2 FLAIR+delayed 
phase 3D T1 GRE
p value
Parenchymal metastases 162
Number of metastasis 146 162   0.003
Sensitivity (%) 90.5712 100 <0.001
ICC 0.975 0.941
DD, double dose; Gd, gadolinium; FLAIR, fluid-attenuated inversion recovery; GRE, gradient echo; ICC, intraclass correlation coefficient.
Data are means±SD.
A B C
Fig. 4. A 49-year-old male patient with renal cell cancer. (A) On early DD Gd-enhanced 3D T1 GRE, brain metastasis is not detected. (B) On late phase DD Gd en-
hanced 3D T2 FLAIR, small enhancing metastasis is clearly demonstrated in the right frontal lobe (arrow). (C) Two month follow up 3D T1 GRE reveals the small 
brain metastases in the right frontal lobe (dashed arrow). DD, double dose; Gd, gadolinium; FLAIR, fluid-attenuated inversion recovery; GRE, gradient echo.
A B
Fig. 3. 68-year-old female patient with lung cancer. (A) In first review, both 
reviewers missed the left frontal small brain metastases on early phase DD 
Gd enhanced 3D T1 GRE, because they regarded them as enhancement of 
the cortical vein. (B) On late phase DD Gd enhanced 3D T2 FLAIR, the same 
lesion with high signal intensity was more prominent and distinct from the 
surrounding normal parenchyma. Both reviewers retrospectively detected 
the left frontal lesion on 3D T1 GRE after reviewing the 3D T2 FLAIR. DD, 
double dose; Gd, gadolinium; FLAIR, fluid-attenuated inversion recovery; 
GRE, gradient echo.
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metastasis might interrupt detection of another lesion. On 
the other hand, peri-lesional minimal edema surrounding 
small lesions might make them appear larger and more 
conspicuous.
There are several limitations to our study. First, because 
we did not include precontrast 3D T2 FLAIR in our proto-
col, it is difficult to define true enhancing lesions on DD Gd-
enhanced 3D T2 FLAIR. Therefore, enhancing lesions on 
FLAIR, which were not detected on T1 GRE, could be false 
positives. To reduce these errors, we carefully defined en-
hancing lesions on 3D FLAIR according to their location, 
morphology, and signal intensity, as stated in the materials 
and methods. However, enhancing lesions on 3D T2 FLAIR 
not detected on 3D T1 GRE should be carefully interpreted. 
Therefore, DD Gd enhanced 3D T2 FLAIR should be con-
sidered complementary to DD enhanced T1 GRE rather 
than replacing it in the detection of brain metastases. Sec-
ond, the specificities of 3D T1 GRE alone and 3D T1 GRE 
plus 3D FLAIR images were not evaluated in this study. 
We regarded T2 hyperintense lesions, such as leukoaraiosis 
or slow flow on 3D T2 FLAIR, as true negatives. However, 
these lesions were too many to be counted. Practically, the 
specificity of 3D T1 GRE plus 3D T2 FLAIR could not be 
calculated. Third, nephrogenic systemic fibrosis is related 
to higher doses of gadolinium. In our institution, DD Gd 
contrast material is routinely used for metastasis. However, 
the stable Gd contrast agent, ionic cyclic form contrast me-
dium, gadoterate meglumine is used for the DD metastasis 
protocol.24 Furthermore, patients are carefully selected to 
prevent nephrogenic systemic fibrosis; for patients with es-
timated eGFR less than 30 mL/min, the use of gadolinium 
is avoided.
In conclusion, small brain metastases were found to show 
higher signal intensity than large brain metastases on the 
DD Gd enhanced FLAIR images. DD Gd enhanced 3D T2 
FLAIR imaging may have a complementary role to 3D T1 
GRE for evaluating small brain metastases.
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